This inventor holds 1 USPTO granted patent and 2 published patent applications. Top assignee: Astrazeneca Ab. Active years: 2011.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2011
Title: Gareth Ensor: Innovator in Cardiac Treatment
Introduction
Gareth Ensor is a notable inventor based in Loughborough, GB. He has made significant contributions to the field of medicine, particularly in the treatment of cardiac arrhythmias. His innovative work has led to the development of valuable compounds that can aid in the management of heart conditions.
Latest Patents
Gareth Ensor holds a patent for "Oxabispidine compounds for the treatment of cardiac arrhythmias." This patent describes compounds of formula I, wherein R, R, R, R to R, X, Y, and Z have meanings given in the description. These compounds are particularly useful in the prophylaxis and treatment of arrhythmias, specifically atrial and ventricular arrhythmias.
Career Highlights
Gareth is currently employed at AstraZeneca AB, a leading global biopharmaceutical company. His work at AstraZeneca has allowed him to focus on developing innovative solutions for complex health issues, particularly in cardiology.
Collaborations
Gareth has collaborated with notable colleagues, including Christina Olsson and Gert Strandlund. These partnerships have contributed to the advancement of research and development in the field of cardiac treatment.
Conclusion
Gareth Ensor's contributions to the medical field, particularly through his patent on oxabispidine compounds, highlight his commitment to improving patient care in cardiac health. His work continues to inspire innovation in the treatment of arrhythmias.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile